Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Rising Leaders Alles And Fouse Join Celgene Board

This article was originally published in Scrip

Executive Summary

Celgene Corporation has appointed soon-to-be CEO Mark Alles and soon-to-be president and COO Jacqualyn Fouse to its board of directors. Alles has been with Celgene since 2004 and most recently was president and chief operating officer (COO). Celgene has previously announced his promotion to CEO: he will take over from Robert Hugin on March 1, 2016. Prior to being Celgene's president and COO, Alles led the company's hematology and oncology franchise. Currently president of the hematology and oncology franchise, Fouse has been with Celgene since 2010 and was previously Celgene's chief financial officer. Fouse will be promoted to president and COO – effective March 1, 2016.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst